![Yamo Deniz](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Yamo Deniz
Nessuna posizione attualmente
Profilo
Yamo Deniz worked as a Director at Cytos Biotechnology AG from 2013 to 2014.
He then worked as the Global Head-Rare Diseases at Genzyme Corp.
After that, he worked as the Vice President & Global-Medical Affairs at Genzyme Corp from 2013 to 2017.
In 2017, he worked as the Chief Medical Officer at Flexion Therapeutics, Inc. He also worked as the Chief Medical Officer at GE UK Group and GE Healthcare Medical Diagnostics.
Dr. Deniz completed his undergraduate degree at the College of the Holy Cross (Massachusetts) and earned a doctorate degree from the University of Massachusetts Medical School.
Precedenti posizioni note di Yamo Deniz
Società | Posizione | Fine |
---|---|---|
FLEXION THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 01/12/2017 |
Genzyme Corp.
![]() Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Direttore Tecnico/Scientifico/R&S | 01/01/2017 |
Cytos Biotechnology AG
![]() Cytos Biotechnology AG Miscellaneous Commercial ServicesCommercial Services Cytos Biotechnology AG engages in the development and commercialization of biopharmaceutical products. The company was founded by Wolfgang A. Renner, James E. Bailey and Hans M. Eppenberger in February 1995 and is headquartered in Zurich, Switzerland. | Direttore/Membro del Consiglio | 31/05/2014 |
GE Healthcare Medical Diagnostics | Direttore Tecnico/Scientifico/R&S | - |
Genzyme Corp.
![]() Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Formazione di Yamo Deniz
College of the Holy Cross (Massachusetts) | Undergraduate Degree |
UMass Chan Medical School | Doctorate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 5 |
---|---|
Genzyme Corp.
![]() Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Flexion Therapeutics, Inc.
![]() Flexion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Flexion Therapeutics, Inc. operates as a biopharmaceutical company, which engages in the development and commercialization of novel and local therapies. It specializes in the treatment of patients with musculoskeletal conditions including osteoarthritis. It offers products under the Zilretta brand, an extended-release corticosteroid approved to manage osteoarthritis knee pain. The company was founded by Michael D. Clayman and Neil Bodick on November 5, 2007 and is headquartered in Burlington, MA. | Health Technology |
Cytos Biotechnology AG
![]() Cytos Biotechnology AG Miscellaneous Commercial ServicesCommercial Services Cytos Biotechnology AG engages in the development and commercialization of biopharmaceutical products. The company was founded by Wolfgang A. Renner, James E. Bailey and Hans M. Eppenberger in February 1995 and is headquartered in Zurich, Switzerland. | Commercial Services |
GE UK Group
![]() GE UK Group MiscellaneousMiscellaneous Part of GE Aerospace, GE UK Group is an investment holding company. GE UK Group is based in Altrincham, UK. The British company was founded in 2008. The CEO is Kevin Michael O'Neill. | Miscellaneous |
GE Healthcare Medical Diagnostics |
- Borsa valori
- Insiders
- Yamo Deniz